Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of August 11th, we are planning to work on 16 projects, including:

Reimbursement

1. Working on market access strategy for the administration of a medication in outpatient settings in England, France, Germany, and Sweden 
2. Working on market access strategy for diagnostic tests in the neurology area in England, France, Germany, Italy, and Spain
3. Working on reimbursement analysis for minimally invasive cardiovascular technology in 11 European countries
4. Working on reimbursement analysis for cardiovascular surgical procedures in England, France, Germany, and Italy
5. Working on reimbursement analysis for molecular diagnostic technologies in 12 European countries
6. Working on reimbursement analysis for neurovascular technologies in eight European countries
7. Working on coding mapping for cardiac, gastrointestinal, and peripheral vascular procedures in Finland, Norway, and Sweden
8. Initiating work on reimbursement analysis for cardiovascular technologies in England and France
9. Initiating work on reimbursement analysis for medical aids used in the urology area in France, Germany, and Italy
10. Initiating work on reimbursement analysis for imaging techniques in 11 European countries
11. Initiating work on reimbursement analysis for cardiac devices in 10 European countries

HEOR

1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
2. Working on a systematic review and meta-analysis for an in vitro diagnostic test
3. Working on evidence gap analysis for in vitro diagnostic tests in the neurology area 
4. Working on a clinical value dossier for an in vitro diagnostic test in the neurology area 
5. Initiating work on evidence gap analysis for medical aids used in the urology area in France and Germany

Let us know if you need any market access or HEOR support for your medical technology in Europe.